Pretransplant Levels of CRP and Interleukin-6 Family Cytokines; Effects on Outcome after Allogeneic Stem Cell Transplantation

Pretransplant Levels of CRP and Interleukin-6 Family Cytokines; Effects on Outcome after Allogeneic Stem Cell Transplantation

Several pretransplant factors, including CRP (C-reactive protein) levels, reflect the risk of complications after allogeneic stem cell transplantation. IL-6 induces CRP increase, and we therefore investigated the effects of pretransplant IL-6, soluble IL-6 receptors, IL-6 family cytokines and CRP se...

Full description

Bibliographic Details
Main Authors:	Tor Henrik Tvedt, Stein Atle Lie, Håkon Reikvam, Kristin Paulsen Rye, Roald Lindås, Tobias Gedde-Dahl, Aymen Bushra Ahmed, Øystein Bruserud
Format:	Article
Language:	English
Published:	MDPI AG 2016-11-01
Series:	International Journal of Molecular Sciences
Subjects:	allogeneic stem cell transplantation interleukin 6 interleukin 31 C reactive protein graft versus host disease comorbidity fluid retention
Online Access:	http://www.mdpi.com/1422-0067/17/11/1823

Similar Items

IL-6 Responsiveness of CD4<sup>+</sup> and CD8<sup>+</sup> T Cells after Allogeneic Stem Cell Transplantation Differs between Patients and Is Associated with Previous Acute Graft versus Host Disease and Pretransplant Antithymocyte Globulin Therapy
by: Tor Henrik Anderson Tvedt, et al.
Published: (2022-04-01)

Pretransplant Systemic Lipidomic Profiles in Allogeneic Stem Cell Transplant Recipients
by: Kimberley Joanne Hatfield, et al.
Published: (2022-06-01)

Patients with Treatment-Requiring Chronic Graft versus Host Disease after Allogeneic Stem Cell Transplantation Have Altered Metabolic Profiles due to the Disease and Immunosuppressive Therapy: Potential Implication for Biomarkers
by: Håkon Reikvam, et al.
Published: (2018-01-01)

Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia—Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation
by: Øystein Bruserud, et al.
Published: (2021-05-01)

Cytokine Release Syndrome in the Immunotherapy of Hematological Malignancies: The Biology behind and Possible Clinical Consequences
by: Tor Henrik Anderson Tvedt, et al.
Published: (2021-11-01)

"PREDICTIVE SIGNIFICANCE OF SERUM INTERLEUKIN-10 FOR ACUTE GRAFT VERSUS HOST DISEASE PRIOR TO ALLOGENEIC BONE MARROW TRASPLANTATION "
by: M. Iravani, et al.
Published: (2005-06-01)

The Acute Phase Reaction and Its Prognostic Impact in Patients with Head and Neck Squamous Cell Carcinoma: Single Biomarkers Including C-Reactive Protein Versus Biomarker Profiles
by: Helene Hersvik Aarstad, et al.
Published: (2020-10-01)

Musculoskeletal Chronic Graft versus Host Disease—A Rare Complication to Allogeneic Hematopoietic Stem Cell Transplant: A Case-Based Report and Review of the Literature
by: Alexander Dåtland Kvinge, et al.
Published: (2022-11-01)

Interleukin-18 and Hematopoietic Recovery after Allogeneic Stem Cell Transplantation
by: Aleksandar Radujkovic, et al.
Published: (2020-09-01)

Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
by: Katrine Kielsen, et al.
Published: (2018-02-01)

Analysis of interleukin-36 expression in tears of allogeneic hematopoietic stem cell transplantation patients and its correlation with the ocular surface microenvironment
by: Yi-Ning Wang, et al.
Published: (2023-07-01)

Role of interleukin-6 polymorphism in acute graft-versus-host disease risk prediction in allogeneic hematopoietic stem cell transplantation
by: Afshan Noor, et al.
Published: (2022-01-01)

Treatment of refractory chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with low-dose interleukin-2
by: I. S. Moiseev, et al.
Published: (2015-12-01)

Responses of regulatory and effector T-cells to low-dose interleukin-2 differ depending on the immune environment after allogeneic stem cell transplantation
by: Yusuke Meguri, et al.
Published: (2022-08-01)

Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation
by: Linlu Tian, et al.
Published: (2022-08-01)

Endocan in Acute Leukemia: Current Knowledge and Future Perspectives
by: Håkon Reikvam, et al.
Published: (2022-03-01)

Allogeneic Stem Cell Transplantation in Multiple Myeloma
by: Christine Greil, et al.
Published: (2021-12-01)

Association of IL-12 and TNF-α Polymorphisms with Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients
by: M H Karimi, et al.
Published: (2019-02-01)

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
by: Kyle B. Lupo, et al.
Published: (2019-06-01)

Comparison of Post-transplant Cyclophosphamide Containing Immunosuppressive Regimen with Standard Immunosuppressive Regimen in Allogeneic Stem Cell Transplantation from Matched Sibling Donor
by: Osman KARA, et al.
Published: (2021-12-01)

Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional Experience
by: Justin Jiang, et al.
Published: (2022-11-01)

Clinical Aspects Of Sclerodermatous Type Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
by: Hatice Şanlı, et al.
Published: (2010-06-01)

Clinical aspects of sclerodermatous type graft-versus-host disease after allogeneic hematopoietic cell transplantation
by: Hatice Şanlı, et al.
Published: (2010-06-01)

In vitro and in vivo Evidence on Intra-tumor Injection of Allogeneic Serum for Immunotherapy in a Mouse Model of Colon Cancer
by: Erfan Basirat, et al.
Published: (2022-10-01)

Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome
by: Raffaella Greco, et al.
Published: (2021-03-01)

Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation
by: Zachariah DeFilipp, et al.
Published: (2019-08-01)

Effect of Early Post-Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation
by: Nidhi Sharma, et al.
Published: (2021-02-01)

Incidence of ocular manifestations in patients with graft versus host disease after allogeneic stem cell transplant in Riyadh, Saudi Arabia
by: Tariq Aldebasi, et al.
Published: (2022-07-01)

Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation
by: Dionysios Vythoulkas, et al.
Published: (2023-01-01)

IL-1-IL-17 Signaling Axis Contributes to Fibrosis and Inflammation in Two Different Murine Models of Systemic Sclerosis
by: Min-Jung Park, et al.
Published: (2018-07-01)

Lower expression of NOTCH components in peripheral blood mononuclear cells of allogeneic hematopoietic cell transplant patients
by: Marcos Paulo Colella, et al.
Published: (2023-07-01)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
by: Grażyna Kaminska-Winciorek, et al.
Published: (2020-07-01)

CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations
by: Hiroshi Takahashi, et al.
Published: (2015-01-01)

Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma
by: Rahim Farahani, et al.
Published: (2014-01-01)

Alterations of Peripheral Blood T Cell Subsets following Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation
by: Ann-Kristin Schmaelter, et al.
Published: (2021-11-01)

Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants
by: Maria Iacobescu, et al.
Published: (2024-02-01)

Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation
by: T A Bykova, et al.
Published: (2013-08-01)

Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation
by: Hideaki Fujiwara
Published: (2021-08-01)

The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation
by: Natalie Köhler, et al.
Published: (2021-03-01)

Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide
by: Raffaella Greco, et al.
Published: (2019-10-01)